Viewing Study NCT00227669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-01-25 @ 2:39 AM
Study NCT ID: NCT00227669
Status: COMPLETED
Last Update Posted: 2016-08-30
First Post: 2005-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
Sponsor: UNICANCER
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None uterine leiomyosarcoma View
None stage III adult soft tissue sarcoma View
None stage IV adult soft tissue sarcoma View
None recurrent adult soft tissue sarcoma View
None stage III uterine sarcoma View
None stage IV uterine sarcoma View
None recurrent uterine sarcoma View
None adult leiomyosarcoma View